Clinical Trial Update: Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant Glioma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study of Vorasidenib in combination with temozolomide for IDH-mutant glioma, with the trial currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idh1-mutant Glioma
• Idh2-mutant Glioma

Drugs mentioned

• Temozolomide (Temozolomide)
• Vorasidenib (vorasidenib)

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: IDH1-mutant Glioma, IDH2-mutant Glioma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING